Health & Medicine

Latest press releases filed to this category.

Ardelyx ·

Ardelyx Wins Multiple Awards at PM360 Trailblazer Awards

WALTHAM, Mass. -- Ardelyx, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, has earned multiple honors at the 2026 PM360 Trailblazer Awards, recognizing the …

Eli Lilly and Company ·

EBGLYSS Improves Hand and Foot Atopic Dermatitis Symptoms

INDIANAPOLIS -- Eli Lilly and Company today announced significant and rapid improvements in skin clearance, itch, and pain for adults and adolescents with moderate-to-severe hand and foot atopic dermatitis (AD), based on data from the Phase …

Holistic Health Labs ·

Holistic Health Labs Updates Vision Alive Max with MaquiBright Extract

New York, USA -- Holistic Health Labs, a supplement company focused on formulas built around named, standardized ingredients at research-matched doses, has announced that its flagship eye-nutrition formula, Vision Alive Max, now features MaquiBright®, the branded, …

Cherry Street Health Group ·

Cherry Street Health Group Named Top Patient Satisfaction Clinic in Danvers

DANVERS, MA, UNITED STATES -- Cherry Street Health Group, a Danvers chiropractic and holistic pain clinic, has been named the highest patient satisfaction provider in the 2026 Danvers category by the Consumer Ratings Institute. The clinic …

Rafael Holdings, Inc ·

Rafael Holdings Announces Pivotal Phase 3 Results for Trappsol® Cyclo™ in NPC

Rafael Holdings, Inc. has announced the topline results from its pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ in patients with Niemann-Pick Disease Type C (NPC). The study, which enrolled 94 patients ranging in age from 3 to 70 years, …

Adlai Nortye ·

Adlai Nortye Appoints New Head for Investor Relations

SINGAPORE and NORTH BRUNSWICK, N.J. -- SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 /CourierPR/ -- Liu, who brings nearly a decade of equity research experience, with a focus on biotechnology and oncology, will work closely with the Adlai Nortye team to deepen engagement with investors …

Raj Devalapalli ·

Simple Lives and Thoughts Encourages Purpose and Gratitude

NEW YORK CITY, NY, UNITED STATES -- NEW YORK CITY, NY, UNITED STATES, September 30, 2026 /CourierPR/ -- Raj Devalapalli Shares His Reflections on Life’s Simple Moments in "Simple Lives and Simple Thoughts" …

Italfarmaco S.p.A ·

Italfarmaco Presents New Givinostat Data on Preserving Upper Limb Function in Duchenne Muscular Dystrophy

Italfarmaco S.p.A. announced new long-term data from the ongoing Phase 3 EPIDYS open-label extension (OLE) study, which suggests that givinostat treatment may help preserve upper limb function in boys with Duchenne muscular dystrophy (DMD). The findings were presented at the …

Shanghai Tablet Press Mechanical Components Co., Ltd. (TPCF) ·

Five Chinese Capsule Filling Machine Manufacturers Advancing Pharmaceutical Manufacturing Industry

CALIFORNIA, CA, UNITED STATES -- An Overview of Capsule Filling Machine Technology, Manufacturing and Pharmaceutical Applications …

Nitun Ahir Scholarship ·

Nitun Ahir Scholarship Opens for Medical Students

The Nitun Ahir Scholarship for Medical Students has announced an upcoming opportunity for undergraduate students pursuing medical education or a confirmed pre-med/doctorate track. The scholarship invites academically qualified students to present thoughtful perspectives on how innovative and holistic approaches can …

DBV Technologies ·

DBV Submits BLA for Peanut Patch in Children

DBV Technologies, a late-stage biopharmaceutical company listed on Euronext and the Nasdaq Stock Market, today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the VIASKIN® Peanut Patch in children with …

BetterLife Pharma Inc ·

BetterLife Pharma Reschedules Annual Meeting

BetterLife Pharma Inc., an emerging biotechnology company primarily focused on developing and commercializing BETR-001 to treat various neurological disorders, today announced that its upcoming Annual General Meeting ("AGM"), originally scheduled for October 14, 2026, has been rescheduled and reclassified as …

Ridgeway Pharmacy Ltd ·

Ridgeway Pharmacy Data Breach Compromises Personal Information

OKLAHOMA CITY -- On or around August 21, 2026, Ridgeway Pharmacy Ltd. became aware of suspicious activity on its computer network, indicating a data breach. Based on a subsequent forensic investigation, Ridgeway determined that cybercriminals had …

Caracal Products & Services ·

Caracal Launches New Hub for Baltimore Health Care Recycling

BALTIMORE -- Caracal Products & Services, a leading provider of health care solutions and recycling services, has announced the launch of a new hub in Baltimore, Maryland. The new facility, located at 2-6 Alco Place, will …

Stuart Curry Dentistry ·

Stuart Curry Dentistry Offers Porcelain Veneers in Vestavia Hills

Stuart Curry Dentistry is offering porcelain veneers to patients in Vestavia Hills, Cahaba Heights, and surrounding communities who want to improve the look of chipped, stained, worn, or uneven front teeth. The dental practice, located at 4851 Cahaba River Road, …

GPC Dental ·

Dr. Po Recognized as NJ Top Dentist 2026

Dr. Cecilio P. Po of GPC Dental has been recognized as a 2026 NJ Top Dentist by NJ Top Dentists, a division of NJ Top Docs. The honor comes after the organization reviewed and approved Dr. Po based on merit.

Dimora Medical ·

Dimora Medical Enhances Wound Care for Elderly

NEW YORK -- The world observes the 2026 United Nations International Day of Older Persons, with a focus on how societies can adapt to support healthier, more dignified aging. Against this backdrop, Dimora Medical, a pioneer …

Phylo ·

Phylo Launches Tool to Speed Up Drug Target Selection

SOUTH SAN FRANCISCO, Calif. -- Phylo, a leading AI-driven platform for biomedical research, today unveiled Target Atlas, an innovative tool designed to streamline the process of identifying and prioritizing drug targets. The new app, built on …

Venture Medical ·

Venture Medical Acquires Medipyxis to Streamline Wound Care Practices

MISSOULA, MT, UNITED STATES -- Venture Medical, LLC, an advanced wound care solutions company based in Missoula, Montana, has acquired Medipyxis, Inc., a developer of a purpose-built electronic medical record and operating system for wound care …

Life Extension ·

Digital Eye Support Offers Relief for Blue Light Strain

Fort Lauderdale, FL -- In today’s digital world, extensive daily use of electronic devices is unavoidable, and it can have significant effects on eye health. According to a review published in the BMJ Open Ophthalmology journal, …

Demy-Colton ·

BioFuture 2026 Conference Announces Agenda

NEW YORK -- BioFuture 2026, a two-day program featuring 100+ speakers and 50+ presenting companies, is set to explore the future of biopharma and healthcare. Taking place October 27-28 at Cure, 345 Park Avenue South in …

Packaging Compliance Labs ·

PCL Expands into Pharmaceutical Testing Market

GRAND RAPIDS, Mich. -- Packaging Compliance Labs (PCL) is making a significant move into the pharmaceutical testing market by investing in a dedicated cGMP pharma lab and state-of-the-art capital equipment.

Vivos Therapeutics, Inc ·

Vivos Therapeutics Sees Cost Reductions and Revenue Growth Initiatives

LITTLETON, Colo. -- Vivos Therapeutics, Inc., a medical device and healthcare services company focused on developing and commercializing diagnostic and treatment methods for patients with obstructive sleep apnea (OSA) and other breathing and sleep disorders, today …

InfraScan, Inc ·

Infrascanner Reduces TBI Treatment Times in Combat Settings

MEDIA, Pa. -- A new study presented at the 2026 Military Health System Research Symposium (MHSRS) has demonstrated the potential of the Infrascanner, a portable brain injury assessment device, in reducing evacuation and surgical treatment times …

uniQure ·

uniQure Reports Positive Data on Gene Therapy for Huntington’s Disease

uniQure, a leading gene therapy company, announced additional data from ongoing Phase I/II studies of ifezuntirgene inilparvovec (AMT-130) for the treatment of Huntington’s disease. The data, which includes results from 12 high-dose patients at 48 months, continue to show meaningful …

OKYO Pharma Limited ·

OKYO Pharma Presents at Ophthalmic Conferences

LONDON and NEW YORK -- LONDON and NEW YORK, Sept. 29, 2026 /CourierPR/ -- OKYO Pharma Limited, a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, has announced its continued commitment to the optometry …

Cascade Prodrug Inc ·

Cascade Prodrug Appoints Key Ophthalmologist to Board

EUGENE, Ore. -- Cascade Prodrug Inc., a biotechnology company developing a paradigm-shifting antiangiogenic prodrug for ophthalmic diseases, today announced the appointment of Kenneth Mandell, M.D., Ph.D., to its Board of Directors. Dr. Mandell is a Harvard-trained …

Ocugen, Inc ·

Ocugen to Present at Biotech Conferences

MALVERN, Pa. -- Ocugen, Inc., a pioneering biotechnology company dedicated to developing gene therapies for blindness diseases, has announced that its executive leadership team will participate in two upcoming investor and industry conferences. These conferences provide …

Immix Biopharma, Inc ·

Immix Biopharma Announces $125M Stock Offering

LOS ANGELES -- Immix Biopharma, a global leader in relapsed/refractory AL Amyloidosis, has announced a significant underwritten registered offering of its common stock. The company has priced this offering at a public offering price of $11.00 …

Astrin Biosciences ·

Certitude Test Now Available to Millions of Women Nationwide

SAINT PAUL, Minn. -- Astrin Biosciences, a cancer intelligence company that uses deep proteomics and artificial intelligence to transform cancer detection and treatment, today announced that its Certitude™ breast cancer screening blood test is now available …

Caspian Therapeutics ·

Caspian Therapeutics Unveils KO-7246 as Diabetes Treatment Candidate

Caspian Therapeutics, Inc., a company pioneering menin-directed therapies in diabetes and other cardiometabolic diseases, today announced comprehensive preclinical data supporting KO-7246 as a potential best-in-class menin inhibitor for diabetes. The data, generated by Kura Oncology prior to Caspian’s launch in …

Kither Biotech ·

Kither Biotech Initiates Phase 1b/2a Study of KIT2014 for COPD

TURIN, Italy -- Kither Biotech, a clinical-stage biopharmaceutical company based in Australia, has initiated dosing of patients in a Phase 1b/2a clinical study of its novel inhaled peptide therapy, KIT2014, for chronic obstructive pulmonary disease (COPD).

iRegene Therapeutics ·

iRegene Therapeutics Advances NouvSight001 for Retinitis Pigmentosa Clinical Trials

CHENGDU, China -- iRegene Therapeutics has advanced its investigational cell therapy, NouvSight001, into clinical development for retinitis pigmentosa (RP), a group of inherited retinal degenerative diseases affecting approximately 1.5 million people worldwide. The therapy, developed using …

Attovia Therapeutics ·

Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV and FCD Conferences

SAN CARLOS, Calif. -- Attovia Therapeutics, a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases, will present new clinical, translational, and preclinical data across its pipeline at the European Academy of Dermatology and Venereology (EADV) …

Nyxoah ·

Nyxoah Appoints New CEO to Focus on U.S. Market

Nyxoah, a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the appointment of Liam Kelly as Chief Executive Officer, effective October 1, 2026. The appointment reflects Nyxoah's continued evolution into a …

Eden Radioisotopes ·

Eden Radioisotopes Advances Medical Isotope Project in New Mexico

ALBUQUERQUE, N.M. -- The medical isotope production facility in Lea County, New Mexico, is set to be North America's first purpose-built reactor and processing facility. Eden Radioisotopes, the company behind the project, has made significant progress …

Piedmont Atlanta Hospital ·

Dr. Sanchez Shares Expertise in Structural Heart Procedures

ATLANTA -- Dr. Carlos E. Sanchez, a renowned interventional cardiologist, has joined the faculty for a physician education program at Piedmont Atlanta Hospital, which will focus on transcatheter tricuspid valve replacement (TTVR) using the EVOQUE system …

EvergreenHealth ·

EvergreenHealth Receives $100M Gift from Dean Weidner

KIRKLAND, Wash. -- EvergreenHealth, a community-owned hospital system serving more than one million residents in King and Snohomish counties, has received a transformative $100 million gift from Dean Weidner, the largest donation in the hospital’s history.

First Choice Dental ·

First Choice Dental Offers Comprehensive Dental Care

First Choice Dental is a leading provider of comprehensive dental care services in Waunakee, Wisconsin, dedicated to ensuring that patients receive the best possible care. The clinic offers a wide range of services, including routine check-ups, preventive care, and advanced …

Viome Life Sciences ·

Viome Signs Agreement With Bhutan on Health Research

BELLEVUE, Wash. -- Viome Life Sciences has signed a memorandum of understanding with Druk Holding & Investments Ltd (DHI), the investment arm of the Royal Government of Bhutan, and Gelephu Mindfulness City (GMC), the Special Administrative …

Talk to the desk

Questions before you file?

Volume pricing, corrections, partnerships — whatever doesn't fit a form field. Tell us what you need and we'll size it properly.

Contact us